Recombinant IGF1R (Dalotuzumab Biosimilar) antibody

Catalog No. ABIN7597613

This anti-IGF1R (Dalotuzumab Biosimilar) antibody is a Humanized Chimeric antibody detecting IGF1R (Dalotuzumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant IGF1R (Dalotuzumab Biosimilar) antibody (ABIN7597613)

Target: IGF1R (Dalotuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This IGF1R (Dalotuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IGF1R (Dalotuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Dalotuzumab Biosimilar Antibody

Specificity: CD221, Insulin-like growth factor 1 receptor, IGF1R, Insulin-like growth factor I receptor, IGF-I receptor

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IGF1R (Dalotuzumab Biosimilar)

Target: IGF1R (Dalotuzumab Biosimilar)

Alternative Name: Dalotuzumab Biosimilar

Target Type: Biosimilar

Background: CD221, Insulin-like growth factor 1 receptor, IGF1R, Insulin-like growth factor I receptor, IGF-I receptor

UniProt: P08069

CAS-No: 1005389-60-5